Company page

Thiogenesis Therapeutics Corp

Thiogenesis Therapeutics Corp (Ticker: TTI) is a public company listed in Canada with a market capitalization of approximately CAD 28.7 million. The company focuses on developing innovative therapeutic solutions. As a publicly traded entity, it is subject to regulatory oversight and market dynamics.

profileTTI:TSXVAI content: aiUpdated June 24, 2026/company/thiogenesis-therapeutics-corp/c-xigqf169
Thiogenesis Therapeutics Corp logo
Ticker
TTI:TSXV
Asset type
Stock
Market cap
$28.7M
Sector
Finance
Industry
Financial Conglomerates
Exchange
TSXV
Currency
CAD